<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2026-09-01</publicationDate>
    
        <volume>23</volume>
        <issue>3</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>59651</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Phytochemical Profile and Therapeutic Potential of Tithonia diversifolia: A Critical Review of Pharmacological Activities and Toxicological Considerations</title>

    <authors>
	 


      <author>
       <name>Shaik Kamar Jaha</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Kota Srivalli Maha Lakshmi</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Salman Khan</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Mabbu Viswanath Reddy</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmacology, Jawaharlal Nehru Technological University Kakinada, Andhra Pradesh, India</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">This review critically evaluates the phytochemistry, pharmacological activities, and toxicological profile of Tithonia diversifolia (Asteraceae). Evidence from preclinical studies indicates that the plant contains bioactive constituents, particularly sesquiterpene lactones and chlorogenic acids, which may contribute to anti-inflammatory, antimicrobial, antiparasitic, antioxidant, immunomodulatory, and metabolic effects. However, the reported therapeutic outcomes vary considerably according to extraction solvent, plant source, experimental model, and dose. Available toxicity studies also suggest a relatively narrow safety margin at higher exposure levels, with hepatotoxic, nephrotoxic, and gastrointestinal effects observed in animal models. Current literature is limited by heterogeneous methodologies, inconsistent phytochemical standardization, and the absence of human clinical studies. Future research should prioritize standardized extraction procedures, quantitative marker analysis, pharmacokinetic investigations, and well-designed clinical evaluations before therapeutic applications can be established.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol23no3/phytochemical-profile-and-therapeutic-potential-of-tithonia-diversifolia-a-critical-review-of-pharmacological-activities-and-toxicological-considerations/</fullTextUrl>



      <keywords language="eng">
        <keyword>Anti-hyperglycaemic; Anti-inflammatory; Antimicrobial; Antioxidant activity; Antiparasitic; Immunomodulatory; Mexican Sunflower; Secondary metabolites; Tithonia diversifolia; Toxicity profile</keyword>
      </keywords>

  </record>
</records>